Genetically Engineered Vaccines for Livestock - Global and China Top Players Market Share and Ranking 2023

Publication Month: Mar 2023 | No. of Pages: 162 Published By:
Single User License: US $ 3060
Corporate User License: US $ 5200

According to YH Research, the global market for Genetically Engineered Vaccines for Livestock should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China's market share increased from percent to percent. China Genetically Engineered Vaccines for Livestock market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Genetically Engineered Vaccines for Livestock market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Pig grew percent to account for percent of the total market sales, and Cattle grew percent.
This report studies and analyses global Genetically Engineered Vaccines for Livestock status and future trends, helps the client to determine the Genetically Engineered Vaccines for Livestock market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Genetically Engineered Vaccines for Livestock, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Genetically Engineered Vaccines for Livestock market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Genetically Engineered Vaccines for Livestock sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Genetically Engineered Vaccines for Livestock sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Genetically Engineered Vaccines for Livestock key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Genetically Engineered Vaccines for Livestock key producing regions, capacity, production, and year over year growth
(6) Genetically Engineered Vaccines for Livestock industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer Ingelheim
Indian Immunologicals
China Animal Husbandry Industry Co.,Ltd.
Yebio Bioengineering Co., Ltd Of Qingdao
Jinyu Bio-technology Co.,ltd.
HVRI
Ringpu Biology
Kyoto Biken Laboratories
FATRO
Ceva Santé Animale
Pulike Biological Engineering,Inc.
Wuhan Hvsen Biotechnology CO.,LTD
Jinhe Biotechnology Co., Ltd.
Shanghai Shen Lian Biomedical Corporation
Qingdao Vland Biotech INC.
Market segment by Type, covers
Genetic Recombinant Vaccine
Recombinant Subunit Vaccines
Genetic Vaccine
Market segment by Application, can be divided into
Pig
Cattle
Sheep
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Genetically Engineered Vaccines for Livestock product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Genetically Engineered Vaccines for Livestock market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Genetically Engineered Vaccines for Livestock market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Genetically Engineered Vaccines for Livestock, percent & CAGR, 2018-2029
Chapter 5: Genetically Engineered Vaccines for Livestock industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions

1 Market Overview
1.1 Genetically Engineered Vaccines for Livestock Definition
1.2 Global Genetically Engineered Vaccines for Livestock Market Size and Forecast
1.2.1 By Consumption Value, Global Genetically Engineered Vaccines for Livestock Market Size,2018-2029
1.2.2 By Sales Quantity, Global Genetically Engineered Vaccines for Livestock Market Size,2018-2029
1.2.3 Global Genetically Engineered Vaccines for Livestock Average Selling Price (ASP),2018-2029
1.3 China Genetically Engineered Vaccines for Livestock Market Size and Forecast
1.3.1 By Consumption Value, China Genetically Engineered Vaccines for Livestock Market Size,2018-2029
1.3.2 By Sales Quantity, China Genetically Engineered Vaccines for Livestock Market Size,2018-2029
1.3.3 China Genetically Engineered Vaccines for Livestock Average Selling Price (ASP), 2018-2029
1.4 Share of China Genetically Engineered Vaccines for Livestock Market with Respect to the Global Market
1.4.1 By Consumption Value, China Genetically Engineered Vaccines for Livestock Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Genetically Engineered Vaccines for Livestock Market Share in Global, 2018-2029
1.4.3 Genetically Engineered Vaccines for Livestock Market Size: China VS Global, 2018-2029
1.5 Genetically Engineered Vaccines for Livestock Market Dynamics
1.5.1 Genetically Engineered Vaccines for Livestock Market Drivers
1.5.2 Genetically Engineered Vaccines for Livestock Market Restraints
1.5.3 Genetically Engineered Vaccines for Livestock Industry Trends
1.5.4 Genetically Engineered Vaccines for Livestock Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Genetically Engineered Vaccines for Livestock, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Genetically Engineered Vaccines for Livestock, Global Market Share by Company, 2018-2023
2.3 Genetically Engineered Vaccines for Livestock Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Genetically Engineered Vaccines for Livestock Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Genetically Engineered Vaccines for Livestock Concentration Ratio
2.6 Global Genetically Engineered Vaccines for Livestock Mergers & Acquisitions, Expansion Plans
2.7 Global Genetically Engineered Vaccines for Livestock Manufacturers Product Type
2.8 Head Office and Genetically Engineered Vaccines for Livestock Production Site of Key Manufacturer
2.9 Genetically Engineered Vaccines for Livestock Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Genetically Engineered Vaccines for Livestock, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Genetically Engineered Vaccines for Livestock, China Market Share by Company, 2018-2023
3.3 China Genetically Engineered Vaccines for Livestock Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Genetically Engineered Vaccines for Livestock Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Genetically Engineered Vaccines for Livestock Capacity by Region
4.3 Global Genetically Engineered Vaccines for Livestock Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Genetically Engineered Vaccines for Livestock Production by Region, 2018-2029
4.5 Global Genetically Engineered Vaccines for Livestock Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Genetically Engineered Vaccines for Livestock Industry Chain
5.2 Genetically Engineered Vaccines for Livestock Upstream Analysis
5.2.1 Genetically Engineered Vaccines for Livestock Core Raw Materials
5.2.2 Main Manufacturers of Genetically Engineered Vaccines for Livestock Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Genetically Engineered Vaccines for Livestock Production Mode
5.6 Genetically Engineered Vaccines for Livestock Procurement Model
5.7 Genetically Engineered Vaccines for Livestock Industry Sales Model and Sales Channels
5.7.1 Genetically Engineered Vaccines for Livestock Sales Model
5.7.2 Genetically Engineered Vaccines for Livestock Typical Distributors
6 Sights by Type
6.1 Genetically Engineered Vaccines for Livestock Classification
6.1.1 Genetic Recombinant Vaccine
6.1.2 Recombinant Subunit Vaccines
6.1.3 Genetic Vaccine
6.2 By Type, Global Genetically Engineered Vaccines for Livestock Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Genetically Engineered Vaccines for Livestock Consumption Value, 2018-2029
6.4 By Type, Global Genetically Engineered Vaccines for Livestock Sales Quantity, 2018-2029
6.5 By Type, Global Genetically Engineered Vaccines for Livestock Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Genetically Engineered Vaccines for Livestock Segment by Application
7.1.1 Pig
7.1.2 Cattle
7.1.3 Sheep
7.1.4 Other
7.2 By Application, Global Genetically Engineered Vaccines for Livestock Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Genetically Engineered Vaccines for Livestock Consumption Value, 2018-2029
7.4 By Application, Global Genetically Engineered Vaccines for Livestock Sales Quantity, 2018-2029
7.5 By Application, Global Genetically Engineered Vaccines for Livestock Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Genetically Engineered Vaccines for Livestock Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Genetically Engineered Vaccines for Livestock Consumption Value, 2018-2029
8.3 By Region, Global Genetically Engineered Vaccines for Livestock Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Genetically Engineered Vaccines for Livestock & Forecasts, 2018-2029
8.4.2 By Country, North America Genetically Engineered Vaccines for Livestock Market Size Market Share
8.5 Europe
8.5.1 Europe Genetically Engineered Vaccines for Livestock Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Genetically Engineered Vaccines for Livestock Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Genetically Engineered Vaccines for Livestock Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Genetically Engineered Vaccines for Livestock Market Size Market Share
8.7 South America
8.7.1 South America Genetically Engineered Vaccines for Livestock Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Genetically Engineered Vaccines for Livestock Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Genetically Engineered Vaccines for Livestock Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Genetically Engineered Vaccines for Livestock Consumption Value, 2018-2029
9.3 By Country, Global Genetically Engineered Vaccines for Livestock Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Genetically Engineered Vaccines for Livestock Market Size, 2018-2029
9.4.2 By Type, U.S. Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Genetically Engineered Vaccines for Livestock Market Size, 2018-2029
9.5.2 By Type, Europe Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Genetically Engineered Vaccines for Livestock Market Size, 2018-2029
9.6.2 By Type, China Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Genetically Engineered Vaccines for Livestock Market Size, 2018-2029
9.7.2 By Type, Japan Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Genetically Engineered Vaccines for Livestock Market Size, 2018-2029
9.8.2 By Type, South Korea Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Genetically Engineered Vaccines for Livestock Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Genetically Engineered Vaccines for Livestock Market Size, 2018-2029
9.10.2 By Type, India Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Genetically Engineered Vaccines for Livestock Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Merck
10.1.1 Merck Company Information, Head Office, Market Area, and Industry Position
10.1.2 Merck Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
10.1.3 Merck Genetically Engineered Vaccines for Livestock Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Merck Company Profile and Main Business
10.1.5 Merck Recent Developments
10.2 GSK
10.2.1 GSK Company Information, Head Office, Market Area, and Industry Position
10.2.2 GSK Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
10.2.3 GSK Genetically Engineered Vaccines for Livestock Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 GSK Company Profile and Main Business
10.2.5 GSK Recent Developments
10.3 Sanofi
10.3.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.3.2 Sanofi Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
10.3.3 Sanofi Genetically Engineered Vaccines for Livestock Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Sanofi Company Profile and Main Business
10.3.5 Sanofi Recent Developments
10.4 Zoties
10.4.1 Zoties Company Information, Head Office, Market Area, and Industry Position
10.4.2 Zoties Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
10.4.3 Zoties Genetically Engineered Vaccines for Livestock Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Zoties Company Profile and Main Business
10.4.5 Zoties Recent Developments
10.5 Elanco
10.5.1 Elanco Company Information, Head Office, Market Area, and Industry Position
10.5.2 Elanco Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
10.5.3 Elanco Genetically Engineered Vaccines for Livestock Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Elanco Company Profile and Main Business
10.5.5 Elanco Recent Developments
10.6 Boehringer Ingelheim
10.6.1 Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
10.6.2 Boehringer Ingelheim Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
10.6.3 Boehringer Ingelheim Genetically Engineered Vaccines for Livestock Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Boehringer Ingelheim Company Profile and Main Business
10.6.5 Boehringer Ingelheim Recent Developments
10.7 Indian Immunologicals
10.7.1 Indian Immunologicals Company Information, Head Office, Market Area, and Industry Position
10.7.2 Indian Immunologicals Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
10.7.3 Indian Immunologicals Genetically Engineered Vaccines for Livestock Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Indian Immunologicals Company Profile and Main Business
10.7.5 Indian Immunologicals Recent Developments
10.8 China Animal Husbandry Industry Co.,Ltd.
10.8.1 China Animal Husbandry Industry Co.,Ltd. Company Information, Head Office, Market Area, and Industry Position
10.8.2 China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
10.8.3 China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines for Livestock Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 China Animal Husbandry Industry Co.,Ltd. Company Profile and Main Business
10.8.5 China Animal Husbandry Industry Co.,Ltd. Recent Developments
10.9 Yebio Bioengineering Co., Ltd Of Qingdao
10.9.1 Yebio Bioengineering Co., Ltd Of Qingdao Company Information, Head Office, Market Area, and Industry Position
10.9.2 Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
10.9.3 Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines for Livestock Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Yebio Bioengineering Co., Ltd Of Qingdao Company Profile and Main Business
10.9.5 Yebio Bioengineering Co., Ltd Of Qingdao Recent Developments
10.10 Jinyu Bio-technology Co.,ltd.
10.10.1 Jinyu Bio-technology Co.,ltd. Company Information, Head Office, Market Area, and Industry Position
10.10.2 Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
10.10.3 Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines for Livestock Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Jinyu Bio-technology Co.,ltd. Company Profile and Main Business
10.10.5 Jinyu Bio-technology Co.,ltd. Recent Developments
10.11 HVRI
10.11.1 HVRI Company Information, Head Office, Market Area, and Industry Position
10.11.2 HVRI Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
10.11.3 HVRI Genetically Engineered Vaccines for Livestock Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 HVRI Company Profile and Main Business
10.11.5 HVRI Recent Developments
10.12 Ringpu Biology
10.12.1 Ringpu Biology Company Information, Head Office, Market Area, and Industry Position
10.12.2 Ringpu Biology Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
10.12.3 Ringpu Biology Genetically Engineered Vaccines for Livestock Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Ringpu Biology Company Profile and Main Business
10.12.5 Ringpu Biology Recent Developments
10.13 Kyoto Biken Laboratories
10.13.1 Kyoto Biken Laboratories Company Information, Head Office, Market Area, and Industry Position
10.13.2 Kyoto Biken Laboratories Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
10.13.3 Kyoto Biken Laboratories Genetically Engineered Vaccines for Livestock Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Kyoto Biken Laboratories Company Profile and Main Business
10.13.5 Kyoto Biken Laboratories Recent Developments
10.14 FATRO
10.14.1 FATRO Company Information, Head Office, Market Area, and Industry Position
10.14.2 FATRO Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
10.14.3 FATRO Genetically Engineered Vaccines for Livestock Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 FATRO Company Profile and Main Business
10.14.5 FATRO Recent Developments
10.15 Ceva Santé Animale
10.15.1 Ceva Santé Animale Company Information, Head Office, Market Area, and Industry Position
10.15.2 Ceva Santé Animale Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
10.15.3 Ceva Santé Animale Genetically Engineered Vaccines for Livestock Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Ceva Santé Animale Company Profile and Main Business
10.15.5 Ceva Santé Animale Recent Developments
10.16 Pulike Biological Engineering,Inc.
10.16.1 Pulike Biological Engineering,Inc. Company Information, Head Office, Market Area, and Industry Position
10.16.2 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
10.16.3 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines for Livestock Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Pulike Biological Engineering,Inc. Company Profile and Main Business
10.16.5 Pulike Biological Engineering,Inc. Recent Developments
10.17 Wuhan Hvsen Biotechnology CO.,LTD
10.17.1 Wuhan Hvsen Biotechnology CO.,LTD Company Information, Head Office, Market Area, and Industry Position
10.17.2 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
10.17.3 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines for Livestock Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Wuhan Hvsen Biotechnology CO.,LTD Company Profile and Main Business
10.17.5 Wuhan Hvsen Biotechnology CO.,LTD Recent Developments
10.18 Jinhe Biotechnology Co., Ltd.
10.18.1 Jinhe Biotechnology Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
10.18.2 Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
10.18.3 Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines for Livestock Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.18.4 Jinhe Biotechnology Co., Ltd. Company Profile and Main Business
10.18.5 Jinhe Biotechnology Co., Ltd. Recent Developments
10.19 Shanghai Shen Lian Biomedical Corporation
10.19.1 Shanghai Shen Lian Biomedical Corporation Company Information, Head Office, Market Area, and Industry Position
10.19.2 Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
10.19.3 Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines for Livestock Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.19.4 Shanghai Shen Lian Biomedical Corporation Company Profile and Main Business
10.19.5 Shanghai Shen Lian Biomedical Corporation Recent Developments
10.20 Qingdao Vland Biotech INC.
10.20.1 Qingdao Vland Biotech INC. Company Information, Head Office, Market Area, and Industry Position
10.20.2 Qingdao Vland Biotech INC. Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
10.20.3 Qingdao Vland Biotech INC. Genetically Engineered Vaccines for Livestock Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.20.4 Qingdao Vland Biotech INC. Company Profile and Main Business
10.20.5 Qingdao Vland Biotech INC. Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

Tables and Figures

Table 1. Genetically Engineered Vaccines for Livestock Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Genetically Engineered Vaccines for Livestock Market Restraints
Table 3. Genetically Engineered Vaccines for Livestock Market Trends
Table 4. Genetically Engineered Vaccines for Livestock Industry Policy
Table 5. Global Genetically Engineered Vaccines for Livestock Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Genetically Engineered Vaccines for Livestock Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Genetically Engineered Vaccines for Livestock Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Genetically Engineered Vaccines for Livestock Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Genetically Engineered Vaccines for Livestock Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Genetically Engineered Vaccines for Livestock Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Genetically Engineered Vaccines for Livestock Mergers & Acquisitions, Expansion Plans
Table 12. Global Genetically Engineered Vaccines for Livestock Manufacturers Product Type
Table 13. Head Office and Genetically Engineered Vaccines for Livestock Production Site of Key Manufacturer
Table 14. Genetically Engineered Vaccines for Livestock Capacity of Major Manufacturers and Future Plan
Table 15. China Genetically Engineered Vaccines for Livestock Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Genetically Engineered Vaccines for Livestock Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Genetically Engineered Vaccines for Livestock Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Genetically Engineered Vaccines for Livestock Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Genetically Engineered Vaccines for Livestock Production by Region, 2018-2023, (K Units)
Table 20. Global Genetically Engineered Vaccines for Livestock Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Genetically Engineered Vaccines for Livestock Upstream (Raw Materials)
Table 22. Global Genetically Engineered Vaccines for Livestock Typical Customers
Table 23. Genetically Engineered Vaccines for Livestock Typical Distributors
Table 24. By Type, Global Genetically Engineered Vaccines for Livestock Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Genetically Engineered Vaccines for Livestock Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Genetically Engineered Vaccines for Livestock Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Genetically Engineered Vaccines for Livestock Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Genetically Engineered Vaccines for Livestock Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Genetically Engineered Vaccines for Livestock Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Genetically Engineered Vaccines for Livestock Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Genetically Engineered Vaccines for Livestock Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Genetically Engineered Vaccines for Livestock Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2018-2029
Table 34. Merck Company Information, Head Office, Market Area, and Industry Position
Table 35. Merck Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
Table 36. Merck Genetically Engineered Vaccines for Livestock Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Merck Company Profile and Main Business
Table 38. Merck Recent Developments
Table 39. GSK Company Information, Head Office, Market Area, and Industry Position
Table 40. GSK Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
Table 41. GSK Genetically Engineered Vaccines for Livestock Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. GSK Company Profile and Main Business
Table 43. GSK Recent Developments
Table 44. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 45. Sanofi Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
Table 46. Sanofi Genetically Engineered Vaccines for Livestock Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Sanofi Company Profile and Main Business
Table 48. Sanofi Recent Developments
Table 49. Zoties Company Information, Head Office, Market Area, and Industry Position
Table 50. Zoties Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
Table 51. Zoties Genetically Engineered Vaccines for Livestock Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Zoties Company Profile and Main Business
Table 53. Zoties Recent Developments
Table 54. Elanco Company Information, Head Office, Market Area, and Industry Position
Table 55. Elanco Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
Table 56. Elanco Genetically Engineered Vaccines for Livestock Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Elanco Company Profile and Main Business
Table 58. Elanco Recent Developments
Table 59. Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
Table 60. Boehringer Ingelheim Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
Table 61. Boehringer Ingelheim Genetically Engineered Vaccines for Livestock Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Boehringer Ingelheim Company Profile and Main Business
Table 63. Boehringer Ingelheim Recent Developments
Table 64. Indian Immunologicals Company Information, Head Office, Market Area, and Industry Position
Table 65. Indian Immunologicals Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
Table 66. Indian Immunologicals Genetically Engineered Vaccines for Livestock Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Indian Immunologicals Company Profile and Main Business
Table 68. Indian Immunologicals Recent Developments
Table 69. China Animal Husbandry Industry Co.,Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 70. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
Table 71. China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines for Livestock Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. China Animal Husbandry Industry Co.,Ltd. Company Profile and Main Business
Table 73. China Animal Husbandry Industry Co.,Ltd. Recent Developments
Table 74. Yebio Bioengineering Co., Ltd Of Qingdao Company Information, Head Office, Market Area, and Industry Position
Table 75. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
Table 76. Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines for Livestock Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Yebio Bioengineering Co., Ltd Of Qingdao Company Profile and Main Business
Table 78. Yebio Bioengineering Co., Ltd Of Qingdao Recent Developments
Table 79. Jinyu Bio-technology Co.,ltd. Company Information, Head Office, Market Area, and Industry Position
Table 80. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
Table 81. Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines for Livestock Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Jinyu Bio-technology Co.,ltd. Company Profile and Main Business
Table 83. Jinyu Bio-technology Co.,ltd. Recent Developments
Table 84. HVRI Company Information, Head Office, Market Area, and Industry Position
Table 85. HVRI Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
Table 86. HVRI Genetically Engineered Vaccines for Livestock Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. HVRI Company Profile and Main Business
Table 88. HVRI Recent Developments
Table 89. Ringpu Biology Company Information, Head Office, Market Area, and Industry Position
Table 90. Ringpu Biology Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
Table 91. Ringpu Biology Genetically Engineered Vaccines for Livestock Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Ringpu Biology Company Profile and Main Business
Table 93. Ringpu Biology Recent Developments
Table 94. Kyoto Biken Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 95. Kyoto Biken Laboratories Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
Table 96. Kyoto Biken Laboratories Genetically Engineered Vaccines for Livestock Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Kyoto Biken Laboratories Company Profile and Main Business
Table 98. Kyoto Biken Laboratories Recent Developments
Table 99. FATRO Company Information, Head Office, Market Area, and Industry Position
Table 100. FATRO Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
Table 101. FATRO Genetically Engineered Vaccines for Livestock Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. FATRO Company Profile and Main Business
Table 103. FATRO Recent Developments
Table 104. Ceva Santé Animale Company Information, Head Office, Market Area, and Industry Position
Table 105. Ceva Santé Animale Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
Table 106. Ceva Santé Animale Genetically Engineered Vaccines for Livestock Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Ceva Santé Animale Company Profile and Main Business
Table 108. Ceva Santé Animale Recent Developments
Table 109. Pulike Biological Engineering,Inc. Company Information, Head Office, Market Area, and Industry Position
Table 110. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
Table 111. Pulike Biological Engineering,Inc. Genetically Engineered Vaccines for Livestock Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Pulike Biological Engineering,Inc. Company Profile and Main Business
Table 113. Pulike Biological Engineering,Inc. Recent Developments
Table 114. Wuhan Hvsen Biotechnology CO.,LTD Company Information, Head Office, Market Area, and Industry Position
Table 115. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
Table 116. Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines for Livestock Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Wuhan Hvsen Biotechnology CO.,LTD Company Profile and Main Business
Table 118. Wuhan Hvsen Biotechnology CO.,LTD Recent Developments
Table 119. Jinhe Biotechnology Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 120. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
Table 121. Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines for Livestock Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. Jinhe Biotechnology Co., Ltd. Company Profile and Main Business
Table 123. Jinhe Biotechnology Co., Ltd. Recent Developments
Table 124. Shanghai Shen Lian Biomedical Corporation Company Information, Head Office, Market Area, and Industry Position
Table 125. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
Table 126. Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines for Livestock Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 127. Shanghai Shen Lian Biomedical Corporation Company Profile and Main Business
Table 128. Shanghai Shen Lian Biomedical Corporation Recent Developments
Table 129. Qingdao Vland Biotech INC. Company Information, Head Office, Market Area, and Industry Position
Table 130. Qingdao Vland Biotech INC. Genetically Engineered Vaccines for Livestock Models, Specifications, and Application
Table 131. Qingdao Vland Biotech INC. Genetically Engineered Vaccines for Livestock Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 132. Qingdao Vland Biotech INC. Company Profile and Main Business
Table 133. Qingdao Vland Biotech INC. Recent Developments
List of Figures
Figure 1. Genetically Engineered Vaccines for Livestock Picture
Figure 2. Global Genetically Engineered Vaccines for Livestock Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Genetically Engineered Vaccines for Livestock Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Genetically Engineered Vaccines for Livestock Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Genetically Engineered Vaccines for Livestock Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Genetically Engineered Vaccines for Livestock Sales Quantity (K Units) & (2018-2029)
Figure 7. China Genetically Engineered Vaccines for Livestock Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Genetically Engineered Vaccines for Livestock Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Genetically Engineered Vaccines for Livestock Market Share of Global, 2018-2029
Figure 10. Global Genetically Engineered Vaccines for Livestock Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Genetically Engineered Vaccines for Livestock Key Participants, Market Share, 2022
Figure 12. Global Genetically Engineered Vaccines for Livestock Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Genetically Engineered Vaccines for Livestock Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Genetically Engineered Vaccines for Livestock Production Market Share & Forecast by Region, 2018-2029
Figure 15. Genetically Engineered Vaccines for Livestock Industry Chain
Figure 16. Genetically Engineered Vaccines for Livestock Procurement Model
Figure 17. Genetically Engineered Vaccines for Livestock Sales Model
Figure 18. Genetically Engineered Vaccines for Livestock Sales Channels, Direct Sales, and Distribution
Figure 19. Genetic Recombinant Vaccine
Figure 20. Recombinant Subunit Vaccines
Figure 21. Genetic Vaccine
Figure 22. By Type, Global Genetically Engineered Vaccines for Livestock Consumption Value, 2018-2029, US$ Million
Figure 23. By Type, Global Genetically Engineered Vaccines for Livestock Consumption Value Market Share, 2018-2029
Figure 24. By Type, Global Genetically Engineered Vaccines for Livestock Sales Quantity, 2018-2029, (K Units)
Figure 25. By Type, Global Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2018-2029
Figure 26. By Type, Global Genetically Engineered Vaccines for Livestock Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 27. Pig
Figure 28. Cattle
Figure 29. Sheep
Figure 30. Other
Figure 31. By Application, Global Genetically Engineered Vaccines for Livestock Consumption Value, 2018-2029, US$ Million
Figure 32. By Application, Global Genetically Engineered Vaccines for Livestock Consumption Value Market Share, 2018-2029
Figure 33. By Application, Global Genetically Engineered Vaccines for Livestock Sales Quantity, 2018-2029, (K Units)
Figure 34. By Application, Global Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2018-2029
Figure 35. By Application, Global Genetically Engineered Vaccines for Livestock Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 36. By Region, Global Genetically Engineered Vaccines for Livestock Consumption Value Market Share, 2018-2029
Figure 37. By Region, Global Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2018-2029
Figure 38. North America Genetically Engineered Vaccines for Livestock Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, North America Genetically Engineered Vaccines for Livestock Consumption Value Market Share, 2022
Figure 40. Europe Genetically Engineered Vaccines for Livestock Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, Europe Genetically Engineered Vaccines for Livestock Consumption Value Market Share, 2022
Figure 42. Asia Pacific Genetically Engineered Vaccines for Livestock Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country/Region, Asia Pacific Genetically Engineered Vaccines for Livestock Consumption Value Market Share, 2022
Figure 44. South America Genetically Engineered Vaccines for Livestock Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, South America Genetically Engineered Vaccines for Livestock Consumption Value Market Share, 2022
Figure 46. Middle East & Africa Genetically Engineered Vaccines for Livestock Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 47. U.S. Genetically Engineered Vaccines for Livestock Sales Quantity, 2018-2029, (K Units)
Figure 48. By Type, U.S. Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, U.S. Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
Figure 50. Europe Genetically Engineered Vaccines for Livestock Sales Quantity, 2018-2029, (K Units)
Figure 51. By Type, Europe Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, Europe Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
Figure 53. China Genetically Engineered Vaccines for Livestock Sales Quantity, 2018-2029, (K Units)
Figure 54. By Type, China Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, China Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
Figure 56. Japan Genetically Engineered Vaccines for Livestock Sales Quantity, 2018-2029, (K Units)
Figure 57. By Type, Japan Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, Japan Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
Figure 59. South Korea Genetically Engineered Vaccines for Livestock Sales Quantity, 2018-2029, (K Units)
Figure 60. By Type, South Korea Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, South Korea Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
Figure 62. Southeast Asia Genetically Engineered Vaccines for Livestock Sales Quantity, 2018-2029, (K Units)
Figure 63. By Type, Southeast Asia Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, Southeast Asia Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
Figure 65. India Genetically Engineered Vaccines for Livestock Sales Quantity, 2018-2029, (K Units)
Figure 66. By Type, India Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, India Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
Figure 68. Middle East & Africa Genetically Engineered Vaccines for Livestock Sales Quantity, 2018-2029, (K Units)
Figure 69. By Type, Middle East & Africa Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
Figure 70. By Application, Middle East & Africa Genetically Engineered Vaccines for Livestock Sales Quantity Market Share, 2022 VS 2029
Figure 71. Research Methodology
Figure 72. Breakdown of Primary Interviews
Figure 73. Bottom-up and Top-down Approaches
Figure 74. Top-down Approaches



Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets